Related Experiment Videos
[Perioperative therapy in juvenile pheochromocytoma]
Insights
Perioperative management of pediatric pheochromocytoma involves alpha-blocker phenoxybenzamine for blood pressure stabilization and sodium nitroprusside for intraoperative control. Beta-blocker pindolol manages tachycardia without complications.
Area of Science:
- Pediatric Anesthesiology
- Pediatric Endocrinology
- Cardiovascular Pharmacology
Background:
- Pheochromocytoma is a rare neuroendocrine tumor causing catecholamine excess.
- Pediatric pheochromocytoma presents significant anesthetic challenges due to cardiovascular instability.
- Effective perioperative management is crucial for patient safety and successful tumor extirpation.
Observation:
- This study evaluated the perioperative anesthetic management of 6 pheochromocytomas in 5 children (8-16 years).
- The therapeutic goal was to manage the alpha- and beta-adrenergic cardiovascular effects of catecholamines.
- Preoperative phenoxybenzamine and intraoperative sodium nitroprusside were employed.
Findings:
- Preoperative phenoxybenzamine stabilized blood pressure, while sodium nitroprusside effectively controlled it during surgery.
- Pindolol managed intraoperative tachycardia without inducing arrhythmias.
- Sufficient intravascular volume substitution prevented hypotensive complications; no postoperative cardiac or sympathicomimetic drugs were needed.
Implications:
- This anesthetic approach is effective and safe for pediatric pheochromocytoma.
- Individualized phenoxybenzamine dosing and careful monitoring are essential.
- This strategy minimizes perioperative complications in pediatric pheochromocytoma management.
Abstract:
The article reports on the paediatric-anaesthesiological treatment of 6 phaeochromocytomas in 5 children who were 8 to 16 years of age. Therapeutic recommendations for the perioperative medication of infantile phaeochromocytoma patients are involved. The therapeutic aim of this study was the management of the effects of phaeochromocytoma before and after extirpation of the tumour, the effect of the phaeochromocytoma being of an alpha-adrenergic and beta-adrenergic cardiovascular nature and transmitted by catecholamines. Preoperative stabilization of blood pressure by means of the alpha-blocker phenoxybenzamine and a subsequent intraoperative, controlled reduction of blood pressure by means of sodium nitroprusside were found to be an effective, safe and easily appreciated therapeutic concept for the perioperative care of paediatric phaeochromocytoma patients. Considerable individual differences in dose an duration of the necessary preoperative phenoxybenzamine administration rendered ward control of therapy recommendable. The risk of complete alpha-sympathicolysis by additive drug effects during premedication and induction of anaesthesia, had to be taken into consideration for conducting phenoxybenzamine therapy. Additional administration of the beta-blocker pindolol successfully controlled the intraoperatively manifested tachycardial heart rhythm phases without provoking any complicating arrhythmias. During the entire perioperative treatment of the patients it is mandatory to ensure sufficient substitution of intravascular volume to prevent hypotensive complications. Our patients did not need any cardiac and sympathicomimetic drugs as postoperative administration. None of the patients had any perioperative complications worth mentioning.